Clinical Milestone Payments definition

Clinical Milestone Payments means those amounts payable by Amgen to GENE pursuant to Section 8.5.
Sample 1Sample 2
Clinical Milestone Payments means the payments required by Sections 4.2.1 through 4.2.3, 4.3.1 through 4.3.3, and 4.4.1 through 4.4.3 hereof.
Sample 1

Examples of Clinical Milestone Payments in a sentence

  • Any Clinical Milestone Payments which are deferred by reason of the provisions of this Section 4.2.10(d) shall bear interest from thirty (30) days after the triggering event in question until payment thereof is made by Diatos, in full, at an annual rate equal to “prime” (as quoted in the Western Edition of the Wall Street Journal under the heading “Money Rates” on the next business day following the date of the triggering event).

  • If more than one Clinical Milestone payment in any Region is triggered by the achievement of a Clinical Milestone and the application of Section 4.2.10(c) above, then Diatos shall only be required to pay the highest of such Clinical Milestone Payments within thirty (30) days following the triggering event, and the remainder of the required Clinical Milestone Payments shall be deferred for a period of six (6) months from the date of the triggering event, at which time they shall be paid by Diatos in full.

  • The Clinical Milestone Payments and the Regulatory Milestone Payments shall be made within [REDACTED: Time Period] after receipt from Institution of an invoice for the achievement of each Clinical Milestone and Regulatory Milestone.

  • For clarity, if more than one Clinical Milestone Payment in a Region is triggered by the achievement, in such Region, of a non-Clinical Milestone (i.e. the milestones specified in Sections 4.2.4 through 4.2.6, 4.3.4 through 4.3.6, and 4.4.4 through 4.4.6 hereof), then this Section 4.2.10(d)(ii) shall not apply, and all Clinical Milestone Payments so triggered shall be due within thirty (30) days of the triggering event.

Related to Clinical Milestone Payments

  • Development Milestone Payment shall have the meaning set forth in Section 9.2(a).

  • Milestone Payments has the meaning set forth in Section 4.2.

  • Milestone Payment means a payment identified in the Implementation Plan to be made following the issue of a Satisfaction Certificate in respect of Achievement of the relevant Milestone;

  • Sales Milestone Payment is defined in Section 5.3.

  • Milestone means an event or task described in the Implementation Plan which, if applicable, must be completed by the relevant Milestone Date;

  • Milestone Events has the meaning set forth in Section 3.3 (Milestone Payments).

  • Development Milestone Event has the meaning set forth in Section 7.1.

  • Milestone Event has the meaning set forth in Section 8.4.

  • Milestone 2 means achievement of annual Net Sales of at least $35,000,000 during any Calendar Year ending on or before December 31, 2024.

  • Milestone Payment Date has the meaning set forth in Section 2.4(a).

  • Milestones means control points in the project that help to chart progress. Milestones may correspond to the completion of a key deliverable, allowing the next phase of the work to begin. They may also be needed at intermediary points so that, if problems have arisen, corrective measures can be taken. A milestone may be a critical decision point in the project where, for example, the consortium must decide which of several technologies to adopt for further development.

  • Milestone 1 means achievement of annual Net Sales of at least $20,000,000 during the Calendar Year ending on December 31, 2021.

  • Project Milestone means the project milestone set forth in Schedule-J;

  • Project Milestones means the project milestones set forth in Schedule-G;

  • Milestone Date means the date set against the relevant Milestone in the Implementation Plan;

  • Milestone Dates means the dates for completion of specified Project activities as contained in the Project Schedule.

  • Sublicense Revenue means [***].

  • Performance Milestone means an act or event specified in section 5.1 and described in section 9 of the EPLA.

  • Milestone Schedule means Seller’s milestone schedule, the form of which is attached to this Agreement as Exhibit Q.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Sublicense Fees means all upfront fees, milestone payments and similar license fees received by LICENSEE from its Sublicensees in consideration for the grant of a Sublicense, but excluding:

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Sublicense Revenues means [***].

  • Phase III Clinical Study means a human clinical study of a product on a sufficient number of subjects that is designed to establish that such product is safe and efficacious for its intended use, and to determine warnings, precautions, and adverse reactions that are associated with such product in the dosage range to be prescribed, which trial is intended to support Regulatory Approval of such product, as described in 21 C.F.R. 312.21(c). 1.185. [***] 1.186. [***]

  • Phase I Clinical Trial means a clinical trial conducted in healthy humans or patients, which clinical trial is designed to establish the safety, drug-drug interactions and/or pharmacokinetics of an investigational drug given its intended use, and to support continued testing of such drug in Phase II Clinical Trials.

  • Net Sales means [***].